Downing LLP

Downing LLP is a London-based investment management firm whose venture activity backs established healthcare software and specialized care delivery models through their scale-up phases. The firm sits within a broader asset management group that runs tax-efficient investment products, infrastructure funds, and venture vehicles, giving it longer-dated capital structures than many traditional venture funds. Healthcare exposure concentrates in tech-enabled services and healthcare software, reflecting Downing’s preference for revenue-generating, capital-efficient models. The firm is not framed as an AI-specialist investor, and limited public information is available about specific named investment partners working on healthcare deals.

Downing typically invests at Series A and Series B stages, with checks in the $1M to $5M range, often participating in growth rounds for companies with established commercial traction. Geographic focus is the United Kingdom, with portfolio companies generally headquartered in or operating heavily within the UK. The firm frequently co-invests alongside other UK growth specialists and strategic corporate investors rather than leading early-stage rounds.

Founders engaging with Downing should expect a disciplined, financially-oriented investment process that places significant weight on revenue quality, gross margin, and visibility of unit economics. The firm is well suited to healthcare software and services operators that have moved past product-market fit and want a partner for scaling commercial operations. Pre-revenue companies, deep biotech programs, or founders seeking a hands-on early-stage venture partner will find Downing out of profile. For UK healthcare tech CEOs running businesses with clear commercial momentum, Downing offers patient growth capital aligned to their stage.